Summary of Papers Presented at the 45th Annual McGuire Lecture Series by Irby, Robert
Summary of Papers Presented at the 45th Annual 
McGuire Lecture Series* ** 
ROBERT IRBY, M.D., PROGRAM CHAIRMAN 
Professor of Medicine, Division of Connective Tissue Diseases, 
Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond 
It is the purpose of this presentation to quickly 
review some of the important points of the papers 
which were presented at the 45th Annual McGuire 
Lecture Series on the subject of immunology and 
rheumatic diseases. The first paper was presented 
by Dr. Mullinax who gave a background on the 
historical aspects of immunology, beginning with 
Jenner and cowpox immunology and immunity to 
attenuated smallpox demonstrated in milk maids, 
continuing through the contributions of Pasteur, 
von Pirquet (on serum sickness), Bence Jones, 
and Hargraves (with the LE cell in 1948), down 
to modern immunology with antibody structure by 
Dr. Porter in 1960. Dr. Mullinax also briefly alluded 
to light chains and heavy chains, suggesting that 
there were two domains in light chains and four 
domains in heavy chains. (This subject was later 
presented in more detail by Dr. Franklin.) He then 
turned to the B cells and T cells, indicating ·that 
B cells were producers of humoral or circulating anti-
bodies whereas the T cells dealt more with cellular 
immunity and delayed hypersensitivity. He also in-
troduced the five types of immunoglobulins known 
at this time. 
Dr. Horwitz described the "three R's" of de-
layed hypersensitivity. The three R's included recog-
nition, response, and reaction, all of which con-
tributed to the afferent as well as the efferent limb 
of the inflammatory reaction. He demonstrated 
scanning electron microscopic pictures of B lympho-
cytes showing rough contour in contrast to the T 
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lymphocytes which had a smooth contour. He then 
mentioned how these reactions were studied through 
skin windows and demonstrated the rosette tech-
nique with lymphocytes and sheep red cells. The 
disorders of recognition were due to absence of T 
lymphocytes. The diseases associated with serum in-
hibition of the lymphocyte function included various 
hematologic disorders and solid tumors, SLE, TB, 
multiple sclerosis, hepatitis, and leprosy. He also 
stated that as far as the immunosuppressant effects 
of drugs on delayed hypersensitivity are concerned, 
cyclophosphamide had the greatest effect on the B 
lymphocytes whereas 6-MP had the greatest effect 
on the T lymphocytes. 
Dr. Moncure talked about laboratory studies 
in the diagnosis of rheumatic diseases, covering the 
third component of complement and ANA titers. 
He described the various immunofluorescent patterns 
which we see in SLE-peripheral, homogenous, 
and nucleolar. About one-half of the patients with 
nucleolar patterns are found to have systemic scle-
rosis. He stated that perhaps the ANA test was 
more sensitive and less specific than the LE test. 
Patients with juvenile rheumatoid arthritis were not 
likely to develop positive rheumatoid factor tests . 
Dr. Davis discussed immune complex reactions 
of systemic lupus erythematosus. He demonstrated 
very well the work of Dixon in the original study 
with iodinated bovine serum albumin and anti-BSA 
antibody formation, with incorporation of comple-
ment and deposition of complexes in the skin, joints, 
and heart in complex disease. He also mentioned 
the fact that rheumatoid factor added to the system 
would further precipitate the DNA-anti-DNA in 
the system, possibly indicating the role of rheu-
matoid factor in rheumatoid arthritis. 
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Dr. Rothfield's subject was the diagnosis and 
treatment of lupus nephritis. She mentioned the 
various types of kidney lesions-focal, diffuse, and 
membranous-in SLE nephritis and demonstrated 
beautifully the immunofluorescent pattern in the 
various types. She pointed out that in order to 
study the uptake in the immunofluorescent pattern 
in patients who have membranous glomerulone-
phritis, an H & E section present with the immuno-
fluorescent sample is needed. She also stated ·that 
CNS lupus may have complexes deposited in the 
cord. Elaborating further, Dr. Rothfield indicated 
that focal glomerulonephritis patients do not die of 
renal insufficiency and that hematuria correlated 
closely with activity in SLE. Patients with the dif-
fuse lesions are nearly all dead within three years 
even with prednisone and they have the worst prog-
nosis. All membranous glomerulonephritis patients 
have nephrotic syndrome and in children, particu-
larly, SLE presents a poor prognosis. Dr. Roth-
field's general measures for treatment included rest, 
avoiding sun lig~t and immunizations, proper 
handling of infecti6ns, and avoiding pregnancy. The 
treatment for focal nephritis is steroids. Patients 
with membranous , nephritis do not do well on 
steroids or immunosuppressive drugs such as 
Cytoxan® since this is not an inflammatory lesion 
and, therefore, would not necessarily respond readily 
to them. Diffuse SLE nephritis, of course, is the in-
dication for the use of combined steroid and im-
munosuppressive therapy. The question is still un-
certain as to whether or not this really will prolong 
the life of patients with systemic lupus. 
Next, Dr. Ziff delivered the first McGuire Lec-
ture entitled, "The Rheumatoid Synovium." He 
pointed out that in the rheumatoid synovium there is 
a proliferation of the lining layer as well as an in-
filtration of the deep layer. The two types of cells 
which are present are phagocytic and synthetic cells, 
the synthetic cells being the fluid producers. He also 
mentioned the presence of the IgG rheumatoid fac-
tor complexes which are present in the deep layer. 
The formation of inclusion bodies with release of 
lysosomal enzymes is thought to be one of the 
methods of inflammatory reaction. The second half 
of the cycle is the activation of complement com-
plexes which cause chemotaxis. The A and B cells 
are the cells in the lining layer, whereas the deep 
layer contains deposits of IgG and IgM and deposits 
of C3 and C4. This IgG site was indicated as the 
site at which rheumatoid factor is formed. 
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Dr. Owen spoke about synovial fluid. He dem-
onstrated the value of examining a regular wet-prep 
and how one can use compensated polarized 
microscopy to differentiate between calcium pyro-
phosphate crystals and gouty crystals. He stated 
that rheumatoid arthritis (RA) cells are not diag-
nostic of rheumatoid disease but can be quite helpful 
in diagnosis if present in the synovial fluid. He also 
discussed the benefit of determining synovial fluid 
complement since when elevated, .it is an aid in 
differentiating Reiter's syndrome from some of the 
other nonspecific cases of inflammatory synovitis. 
Dr. O'Brien followed with a discussion of some 
of the newer nonsteroidal anti-inflammatory drugs 
used in the treatment of rheumatoid arthritis. He 
began by covering the use of aspirin, gold, and 
antimalarials. He pointed out that the problem in 
drug evaluation is that in early studies, particularly 
with indomethacin, investigators were not geared 
up for control studies. We now feel that indo-
methacin for treatment of rheumatoid arthritis is 
not as good as it was at first thought to be. It may 
be superior to placebo; perhaps, it is equal to small 
doses of phenylbutazone. Dr. O'Brien maintained 
that a patient should not be placed on a drug study 
unless he was not doing well. He mentioned newer 
preparations under investigation, some of which 
have been discontinued because of fatal hepatitis. 
Some promise was shown for the proprionic acid 
derivatives, one of which was fenoprofen calcium 
which is less :toxic than aspirin. In a dose of 400 
mg per day, it is about as effective as 15 aspirin 
tablets daily without the side effects of aspirin. We 
have been using this drug on an experimental basis 
here for over a year now and find that it is very 
effective in the management of some cases of 
rheumatoid arthritis. He mentioned some of the 
other indole derivatives, all of which have some-
what the same effect as lndocin®. 
On the second day of ·the symposium, Dr. 
Buckley spoke on the immuncxleficiency diseases. 
She discussed agammaglobulinemia associated with 
arthritis and reported four patients who had hypo-
gammaglobulinemia. The B cells in these cases are 
not able to produce lgG. She also discussed selec-
tive lgA deficiency. Some of these patients have 
ataxia telangiectasia and chronic, recurring infec-
tions, atopic disease, autoimmune disease, and 
diarrhea. The lymph node biopsies from these pa-
tients may show two different types of findings. 
The B cell deficits will show absence of the cortical 
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follicles .in the lymph node, whereas the T cell 
deficits may show some derangement in the medulla 
of the lymph node. She demonstrated some of the 
ways of marking B and T cells by using the rosette 
method which Dr. Ziff discussed later. The two 
types of agammaglobulinemia were contrasted-the 
Bruton type and ,the other type in which the plasma 
cells did not secrete lgA. Patients with B cell deficits 
can live to adulthood but severe T cell deficit pa-
tients die within two years. This is the "Swiss" type 
of agammaglobulinemia. Bone marrow ·transplanta-
tion from a histocompatible sibling may be a life-
saver and about half of those done have been 
successful. For treatment of B cell deficiency, she 
indicated that the simple use of y-globulin is not 
sufficient, that all five classes of immunoglobulin 
need to be replaced by plasma infusions in lieu of 
injection of y-globulin. Dr. Buckley encouraged the 
use of the "buddy system," siblings or friends who 
live in the same home who are HAA negative. 
Dr. Calabro talked about juvenile rheumatoid 
arthritis, early diagnosis, management, and prog-
nosis. He indicated that juvenile rheumatoid arthritis 
usually came on before the 16th year of life and 
pointed out the differences in the features of juvenile 
rheumatoid arthritis and adult rheumatoid arthritis. 
The major difference is that adults have rheumatoid 
factor present and juveniles, as a rule, do not. Also, 
subcutaneous nodules are more common in adults 
than in children and the fever, rash, and iritis are 
usually not present in adult rheumatoid arthritis but 
are present in juveniles. Dr. Calabro described three 
modes of onset : the acute febrile or Still's type, the 
polyarticular, where four or more joints are in-
volved, and the monarticular, where only one joint 
is involved. Patients of the third group are more 
likely to develop chronic iridocyclitis and they get 
into real difficulty as time goes on. The fever is a 
"double" type of fever whereby the temperature at 
sometime during the day may go down to below 
normal. The fever usually responds very promptly 
to aspirin in large doses. The Kobner phenomenon, 
similar to an urticaria! type of reaction, is one in 
which ,the rash can be brought out with a simple 
stroke on the skin. Although quite helpful, this is 
not specific for the rash of juvenile rheumatoid 
arthritis in that other types of rashes may behave 
similarly. The laboratory aids here are the presence 
of anemia, elevated ESR and lymphocytosis. These 
children frequently have positive ANA titer, may 
have positive ASO titer, and the x-ray will frequently 
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show periostitis. In Dr. Calabro's 15-year follow-up, 
many of the monarticular patients went on to de-
velop polyarticular states and the same was true for 
patients with the oligoarticular type. Treatment con-
sisted of aspirin, gold salts, and steroids, with 
steroids particularly advisable in the acute febrile 
Still's patient where there was pericardia! or eye 
involvement. 
Dr. Baum discussed ankylosing spondylitis which 
he said was not a variant of rheumatoid arthritis. 
He stated criteria for diagnosis of ankylosing spondy-
litis and demonstrated certain feaures in the ex-
amination of a patient with ankylosing spondylitis. 
A very interesting x-ray finding, the syndesmophyte, 
was discussed-vertical syndesmophytes in spondy-
litis versus horizontal osteophytes in osteoarthritis. 
The various associated complications-aortitis, iritis, 
heart block, amyloidosis, subluxation, and pul-
monary fibrosis-were discussed. The variants of 
ankylosing spondylitis-psoriatic, chronic ulcerative 
colitis, Whipple's, and Reiter's spondylitis-were 
discussed. The work that has been done, particularly 
by Dr. Schlosstein and Dr. Terasaki at Los Angeles 
on the transplant antigen W-27 locus, was sum-
marized. Eighty-eight percent of patients with 
ankylosing spondylitis demonstrated this antigen as 
opposed to :an 8 % incidence in a random popula-
tion. This certainly points to some genetic aspect in 
ankylosing spondylitis. It may also have something 
to do with the prognostic significance, particularly in 
children, if a patient possesses a W-27 antigen locus. 
Dr. Franklin, "Mr. Immunoglobulin," talked 
about the G, A, M, D, and E myelomas and de-
scribed the structure of the immunoglobulin molecule 
with the Fab fraction or the antigen binding site and 
the constant fraction (Fe) of the immunoglobulin. 
He listed the various H-chains and L-chains of IgG, 
A, M, D, and E and talked about the I-chain. By 
the time a diagnosis of multiple myeloma is made, 
the chances are that the patient has had the disease 
some 15 years prior to the time that bone lesions 
appear. The bone pain is usually the factor which 
brings the patient to the doctor. The other disorders, 
macroglobulinemia, H-chain disease, and the benign 
monoclonal gammopathy were discussed. Benign 
monoclonal gammopathy is present in about 3% 
of patients over 60 years of age. There are about 
35 cases of yH-chain, about 50 cases of aH-chain, 
and only 7 cases of µH-chain disease reported. These 
are very rare, but they have certain characteristics of 
yH-chain myeloma and may simulate lymphoma. 
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Palatal and uvula swelling are ·two things which 
sometimes aid in making the diagnosis. Rarely do 
these patients have bone lesions and recurrent infec-
tion is usually the reason for seeking medical atten-
tion. These patients have a characteristic electro-
phoretic pattern. Patients with aH-chain disease 
usually have malignant lymphoma of the intestine 
and malabsorption. The aH-chain is produced in 
the plasma cells lining the intestine and may or may 
not be malignant. Of seven elderly patients with 
µ-chain disease, all had chronic lymphocytic leu-
kemia. Lymphadenopathy is usually absent and these 
patients have hepatosplenomegaly and a high inci-
dence of Bence Jones protein and K-light chains in 
the urine. The finding that is very helpful in diag-
nosis of µ-chain is the presence of a large vacuolated 
plasma cell which can be found in the bone marrow. 
The bad effects caused by these proteins are 
the hyperviscosity syndrome, cryoglobulinemia and 
Bence Jones protein, the latter of which damages 
the kidney. They have bleeding and clotting dis-
orders, infections, hemolytic anemias, and amy-
loidosis. Dr. Glenner and his group at NIH now 
have indicated that light chain fragments are present 
in amyloidosis. 
Dr. Waller discussed the serum agglutinators 
and indicated that rheumatoid factors were IgM, 
whereas the serum agglutinators were antiglobulin 
antibodies or IgG which are a normal constituent of 
serum. These are closely associated with suppurative 
infection, particularly gram-positive organisms. The 
hidden sites on the Fab fragment are responsible 
for the formation of the serum agglutinators after 
papain or pepsin digestion. There are about 14.9% 
positive serum agglutinators in a hospital population 
as opposed to 0.5% in our arthritis clinic. Large 
abscesses usually have positive tests; subacute bac-
terial endocarditis may have positive tests for serum 
agglutinators. 
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Dr. Ziff presented the second McGuire Lecture 
on "Viruses and the Connective Tissue Diseases." 
Again he stated that T cell lymphoblasts in the pres-
ence of antigen can convert B cells into plasma cells 
to produce serum antibody and that virus infections 
would diminish T cell formation. Dr. Ziff discussed 
further the concept of T cell helper and T cell sup-
pressor substances in which he indicated that viruses 
might be an enhancing mechanism to stimulate the 
B cells ·to produce autoantibody. 
Dr. Bisno spoke on the subject of acute rheu-
matic fever and glomerulonephritis with strepto-
coccal antigen. He did mention the fact that ASO is 
frequently elevated in throat infections and not 
necessarily elevated in pyoderma. The sequelae of 
the throat infections are more likely to produce 
acute rheumatic fever than acute glomerulonephritis, 
whereas the sequelae of the skin infections are more 
likely to produce acute glomerulonephritis. Dr. Bisno 
briefly discussed the streptozon test, on which he 
and his associates are now working, which may be 
very helpful in the diagnosis of streptococcal infec-
tion and sequelae. 
Dr. Blaylock's lecture included a discussion of 
urticaria, hives, eczematous dermatitis and rheuma-
toid lesions. IgE is the immunoglobulin which is 
present in patients with urticaria, hay fever, asthma, 
and penicillin allergy. He noted ·that pemphigus 
vulgaris has 7S yG which is usually laid down be-
tween the cells and around the keratinocytes. Gamma 
G globulins will vary in pemphigus vulgaris, whereas 
in bullous pemphigus the serum globulins usually 
stay the same. IgG is usually deposited on the base-
ment membrane similar to that in SLE. Dermatitis 
herpetiformis produces IgA on the basement mem-
brane. 
Dr. Cooke discussed methods of early diagnosis 
of gonococcal arthritis and the absolute necessity of 
instituting prompt treatment. 
